Prosecution Insights
Last updated: October 27, 2026
Application No. 17/893,611

INTRAVASCULAR BLOOD PUMP

Non-Final OA §102§103
Filed
Aug 23, 2022
Priority
Mar 23, 2018 — EU 18163763.8 +2 more
Examiner
D ABREU, MICHAEL JOSEPH
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Abiomed Inc.
OA Round
3 (Non-Final)
68%
Grant Probability
Favorable
3-4
OA Rounds
1m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
494 granted / 730 resolved
-2.3% vs TC avg
Strong +22% interview lift
Without
With
+21.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
34 currently pending
Career history
797
Total Applications
across all art units

Statute-Specific Performance

§101
8.2%
-31.8% vs TC avg
§103
41.1%
+1.1% vs TC avg
§102
31.0%
-9.0% vs TC avg
§112
17.9%
-22.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 730 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments with respect to the previous rejection(s) of the claims have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made as expounded below. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 16-21 and 27-36 rejected under 35 U.S.C. 102(a)(1) as being anticipated by Maher et al. (USP# 5,707,218; hereinafter “Maher”). Regarding claim 16, Maher discloses an intravascular blood pump comprising: a shaft carrying an impeller, the shaft being rotatable (e.g.Fig. 3, #42/44); and a housing having an opening (e.g. Fig. 4, housing top figure with the opening) and an end wall having a sleeve (e.g. Fig. 5, where #40 extends until), a circumferential gap defined by a circumferential surface of the shaft and a surface of the sleeve (e.g. Fig. 5, #84); wherein the shaft extends through the opening with the impeller positioned outside the housing (e.g. Col 5, ll 45-65); and wherein the circumferential gap has a length and a width, the width having a minimum width selected to provide a physical barrier against ingress of red blood cells into the gap (e.g. Col 1, ll ~40 – “In order to prevent blood cells from entering the bearing and being hemolyized, the bearing clearance is made so small that blood cells are essentially precluded from entering the bearing”; Col 2, ll 20-60; Col 4, ll 55-60). Regarding claims 17-21, Maher discloses construction of an intravascular blood pump where the housing comprises a plurality of elements composed of thermoconductive elements including radial outer thermoconductive sleeve composed of silicon carbide (e.g. Col 5, ll 18-45). Regarding claims 27-29, Maher discloses the circumferential gap converges continuously and linearly over at least part of its length up to where the gap has the minimum width, towards an impeller-side end which is an end of the circumferential gap closest to the impeller (e.g. Fig. 3, element 38). Regarding claims 30-32, Maher discloses an outer diameter of the shaft expands towards an impeller-side end which is an end of the circumferential gap closest to the impeller, wherein the outer diameter of the shaft has a circumferential groove stretching over an end of the gap opposite the impeller-side end of the circumferential gap, the outer diameter of the shaft expands from a constant diameter shaft section stretching over an end of the circumferential gap opposite the impeller-side end of the circumferential gap to a maximum outer diameter within the gap (e.g. Col 4, ll 1-14). Regarding claims 33-38, Maher discloses the minimum width of the gap is 2 microns or less (Col 4, ll 55-60 – “gap between the mating surfaces of the balls and their respective cups is extremely small--on the order of 0.25-0.5.mu.”). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. In considering patentability of the claims under 35 U.S.C. 103(a), the examiner presumes that the subject matter of the various claims was commonly owned at the time any inventions covered therein were made absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and invention dates of each claim that was not commonly owned at the time a later invention was made in order for the examiner to consider the applicability of 35 U.S.C. 103(c) and potential 35 U.S.C. 102(e), (f) or (g) prior art under 35 U.S.C. 103(a). The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 22-26 are rejected under 35 U.S.C. 103 as being unpatentable over Maher Regarding claims 22-24, Carrier fails to specifically disclose the minimum width is a particular percentage over the length of the gap or present at the impeller side; however, the examiner notes that the prior art is clear in noting that the parameters and orientation can be adjusted based on the application. Accordingly, the examiner is of the position that it would have been obvious to have the minimum width extending over not more than 20% of the length of the gap, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art. In re Aller, 105 USPQ 233. Regarding claims 25-26, Carrier fails to expressly disclose the length or width of the gap. The examiner notes that the pump is sized to fit within similar vascular structures and is sized for the same purpose as the present invention – to prevent red cells from gathering and clotting. Accordingly, the examiner is of the position that it would have been obvious to have a length of the gap between 1.3-1.7mm, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art. In re Aller, 105 USPQ 233. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Michael D’Abreu whose telephone number is (571) 270-3816. The examiner can normally be reached on 7AM-4PM. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at (571) 270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL J D'ABREU/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Show 1 earlier event
Oct 01, 2024
Non-Final Rejection mailed — §102, §103
Feb 28, 2025
Response Filed
Mar 27, 2025
Non-Final Rejection mailed — §102, §103
Aug 26, 2025
Response Filed
Jan 27, 2026
Response after Non-Final Action
Sep 15, 2026
Request for Continued Examination
Sep 17, 2026
Response after Non-Final Action
Oct 21, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758109
APPARATUS AND METHODS OF MONITORING MATERNAL AND FETAL HEART RATE
3y 5m to grant Granted Oct 13, 2026
Patent 12751622
SYSTEM AND METHOD FOR WRITING INTO THE MEMORY OF AN ACTIVE MEDICAL DEVICE IMPLANTABLE BY TELEMETRY
4y 5m to grant Granted Oct 06, 2026
Patent 12741150
METHOD AND APPARATUS FOR ESTABLISHING PARAMETERS FOR CARDIAC EVENT DETECTION
3y 2m to grant Granted Sep 22, 2026
Patent 12733819
BIOLOGICAL INFORMATION INPUT SYSTEM AND BIOLOGICAL INFORMATION INPUT METHOD
3y 2m to grant Granted Sep 15, 2026
Patent 12728269
DISTRIBUTED IMPLANTABLE HEARING SYSTEMS
5y 8m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
68%
Grant Probability
89%
With Interview (+21.7%)
4y 3m (~1m remaining)
Median Time to Grant
High
PTA Risk
Based on 730 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month